THE Native Antigen Company has launched a new range of tests for the Zika virus, which represents a major step forward in the fight against the disease.

The Oxford-based company’s new non-crossreactive Zika virus tests are more sensitive and accurate than current tests, but can also distinguish between Zika and similar viruses such as Dengue.

The new product range comes as the Oxford-based company reports a third consecutive year of growth

Dr Nick Roesen, COO of The Native Antigen Company, said: “The Zika virus poses a significant global risk and there is currently no vaccine or specific treatment.”